Jennifer Lynn Taylor-Cousar, MD, MSCS
Photo: Jennifer L. Taylor-Cousar



Elected 2020

Dr. Jennifer Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services. She oversees the care of children with pulmonary disease and adults with cystic fibrosis. Dr. Taylor-Cousar is co-director of the Adult CF Program and Director of the CF Therapeutics Development Network (TDN) research that is conducted at NJH. She has been site primary investigator on more than 40 clinical studies, and global site investigator on 3 clinical trials. Her investigator initiated research focuses on the development and evaluation of novel therapies for the treatment of CF, and determination of the etiology and treatment of bronchiectasis in non-human primates.

She serves on numerous local and national committees including the CF Foundation’s Clinical Research Advisory Board, the CF TDN’s Clinical Research Executive Committee and as Chair of the CF TDN’s Women’s Health Research Working Group. She recently completed service on the American Thoracic Society (ATS) Scientific Advisory Committee, and is Chair-Elect for the 2019-2020 ATS Clinical Problems Programming Committee (Chair, 2020-2021). She has co-chaired numerous sessions and given invited lectures at the ATS International Conference, and the North American, European and Australian CF Conferences, as well as at regional CF and pulmonary conferences and national and international veterinary conferences. She is an active member of the Colorado Chapter CF Board.

Dr. Taylor-Cousar received her undergraduate degree in human biology from Stanford University in 1993. She completed her doctorate in medicine in 1998, combined residency in internal medicine and pediatrics in 2002, and her combined fellowship in adult and pediatric pulmonary medicine in 2006 at Duke University Medical Center. Dr. Taylor-Cousar obtained her Master of Clinical Science from the University of Colorado in 2015.